HYPEREOSINOPHILIC SYNDROME IN A MYELOPROLIFERATIVE VARIETY - THERAPEUTIC SUCCESS AFTER AN 18-MONTH TREATMENT WITH INTERFERON-ALPHA

被引：0
|
作者：
DINE, G
NAJMAN, A
BRAHIMI, S
CULIOLI, B
ABID, A
DUPOIRIEUX, J
机构：
[1] HOP HAUTS CLOS,SERV MALAD SANG,F-10003 TROYES,FRANCE
[2] HOP ST ANTOINE,SERV,MALAD SANG,F-75571 PARIS 12,FRANCE
来源：
PRESSE MEDICALE | 1992年 / 21卷 / 37期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1776 / 1776
页数：1
相关论文
共 50 条
  • [21] Influence of interferon-alpha on cytokine expression by the bone marrow microenvironment - Impact on treatment of myeloproliferative disorders
    Peschel, C
    Aulitzky, WE
    Huber, C
    LEUKEMIA & LYMPHOMA, 1996, 22 : 129 - 134
  • [22] Interferon-Alpha in the Treatment of Philadelphia-Negative Chronic Myeloproliferative Neoplasms. Status and Perspectives
    Hasselbalch, Hans Carl
    Larsen, Thomas Stauffer
    Riley, Caroline Hasselbalch
    Jensen, Morten Krogh
    Kiladjian, Jean-Jacques
    CURRENT DRUG TARGETS, 2011, 12 (03) : 392 - 419
  • [23] A case of autoimmune polyglandular syndrome developed after interferon-alpha therapy
    Sasso, FC
    Carbonara, O
    Di Micco, P
    Coppola, L
    Torella, R
    Niglio, A
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 56 (02) : 238 - 239
  • [24] TREATMENT OF ERDHEIM-CHESTER SYNDROME: INTERFERON-ALPHA AND FUTURE PERSPECTIVES
    Trimboli, Domenico
    Graziani, Giorgio
    Haroche, Julien
    Lupica, Rosaria
    Fazio, Maria Rosaria
    Lucisano, Silvia
    Donato, Valentina
    Cernaro, Valeria
    Montalto, Gaetano
    Pettinato, Giuseppina
    Buemi, Michele
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 413 - 413
  • [25] Perspectives on interferon-alpha in the treatment of polycythemia vera and related myeloproliferative neoplasms: minimal residual disease and cure?
    Hasselbalch, Hans Carl
    Holmstroem, Morten Orebo
    SEMINARS IN IMMUNOPATHOLOGY, 2019, 41 (01) : 5 - 19
  • [26] Perspectives on interferon-alpha in the treatment of polycythemia vera and related myeloproliferative neoplasms: minimal residual disease and cure?
    Hans Carl Hasselbalch
    Morten Orebo Holmström
    Seminars in Immunopathology, 2019, 41 : 5 - 19
  • [27] Guillain-Barre syndrome after simultaneous therapy with suramin and interferon-alpha
    Bachmann, T
    Koetter, KP
    Mühler, J
    Fuhrmeister, U
    Seidel, G
    EUROPEAN JOURNAL OF NEUROLOGY, 2003, 10 (05) : 599 - 599
  • [28] Complete molecular remission after interferon alpha treatment in a case of 8p11 myeloproliferative syndrome
    Zhou, Lili
    Fu, Weijun
    Yuan, Zhengang
    Hou, Jian
    LEUKEMIA RESEARCH, 2010, 34 (11) : E306 - E307
  • [29] A PRELIMINARY-STUDY ON THE INTERFERON-ALPHA TREATMENT FOR XEROSTOMIA OF SJOGRENS-SYNDROME
    SHIOZAWA, S
    MORIMOTO, I
    TANAKA, Y
    SHIOZAWA, K
    BRITISH JOURNAL OF RHEUMATOLOGY, 1993, 32 (01): : 52 - 54
  • [30] Favorable response to high-dose interferon-alpha in idiopathic hypereosinophilic syndrome with restrictive cardiomyopathy - Case report and literature review
    Baratta, L
    Afeltra, A
    Delfino, M
    De Castro, S
    Giorgino, F
    Rossi-Fanelli, F
    ANGIOLOGY, 2002, 53 (04) : 465 - 470
12345